Hemostatic material and spray
AssigneeBc3 Technologies, Inc.
InventorsThomas Freier, Rivelino Montenegro, Wayne Grube, JR.
Life of this patent
Estimating the term…
Loading patent…
AssigneeBc3 Technologies, Inc.
InventorsThomas Freier, Rivelino Montenegro, Wayne Grube, JR.
Estimating the term…
A hemostatic material and a method of treating a bleeding wound of a human or an animal include a hemostatic powder for application to the wound. The hemostatic powder comprises a first part consisting of a native chitosan base and a second part consisting of a chitosan salt, where the first and the second parts form the main component of the hemostatic powder, or at least 50% of a total weight of the hemostatic powder, and the second part forms a layer that at least partially coats the first part. The hemostatic powder may be provided in a hemostatic spray formulation that comprises a mixture of the hemostatic powder dispersed in a liquefied gas for release from a cannister onto the wound. A treatment method involves applying the hemostatic spray formulation directly to the wound. Other embodiments are also disclosed.
A hemostatic material for application to a wound of a human or an animal, the hemostatic material comprising at least a first part consisting of a native chitosan base and a second part consisting of a chitosan salt, wherein:
A hemostatic spray formulation for application to a bleeding wound of a person or an animal, comprising:
A method of treating a bleeding wound of a human or an animal, the method comprising applying a hemostatic material to the bleeding wound, wherein at least 50% of a total weight of the hemostatic material is formed from a native chitosan base that is at least partially coated with a chitosan salt.
Dependencies are inferred from the claim text.